mda-mb-468 glutathione content

mda-mb-468 glutathione content Mutant p53 reactivators protect breast cancer cells from ferroptosis - Rathnayake - 2024 - Cell Biochemistry and Function Disclosing a metabolic signature of

Name: mda-mb-468 glutathione content Mutant p53 reactivators protect breast cancer cells from ferroptosis - Rathnayake - 2024 - Cell Biochemistry and Function Disclosing a metabolic signature of
Brand: equiscorp.hu
SKU: 1783585555
Price: 21.93 USD
Availability: InStock
Rating: 4.7956 (21 reviews)

Disclosing a metabolic signature of cisplatin resistance in MDA MB 231 triple negative breast cancer cells by NMR metabolomics Cancer Cell International Springer Nature Link MDA MB 468 Cell Line an overview ScienceDirect Topics Frontiers Dihydroartemisinin Transferrin Adducts Enhance TRAIL Induced Apoptosis in Triple Negative Breast Cancer in a P53 Independent and ROS Dependent Manner Small Peptide Ligands for Targeting EGFR in Triple Negative Breast Cancer Cells Scientific Reports

SKU: 1783585555 · From equiscorp.hu

4.8

USD21.93 USD67.93

Pay in 4 interest-free payments of $5.48 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 1 - Aug 6

Description

Patent Number: 221279

Faseb J 15(2): 306-308

Franklin, G

Research on MOTS-c in ovariectomized mice (a model for postmenopausal metabolic dysfunction) showed reduced fat accumulation in white adipose tissue, increased brown fat activation, and improved insulin sensitivity after just 5 weeks of treatment